Ovid Therapeutics Ratios (2020-2025) | OVID

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -237.56%-386.27%84.70%-11.92%-1,784.23%-107,798.33%-5.17%-20,236.36%-16,544.00%-10,323.85%-6.88%-7,901.35%5,042.01%-8,095.95%-7,873.08%-74.68%-9,210.61%
EBIT Margin -237.25%-378.58%84.73%-11.92%-1,807.46%-115,329.27%-5.47%-22,563.64%-18,896.00%-11,035.78%-8.16%-11,768.24%-12,140.24%-7,645.09%-9,653.85%-80.88%-9,487.12%
EBITDA Margin -237.25%-378.58%84.73%-11.92%-1,807.46%-115,329.27%-5.47%-22,563.64%-18,896.00%-11,035.78%-8.16%-11,768.24%-12,140.24%-7,645.09%-9,653.85%-80.88%-9,487.12%
Operating Margin -237.25%-378.58%84.73%-11.92%-1,807.46%-115,329.27%-5.47%-22,563.64%-18,896.00%-11,035.78%-8.16%-11,768.24%-12,140.24%-7,645.09%-9,653.85%-80.88%-9,487.12%
Net Margin -237.56%-386.27%84.46%-11.76%-1,789.78%-107,798.33%-5.17%-20,236.36%-16,544.00%-10,323.85%-6.88%-7,901.35%5,042.01%-8,095.95%-7,873.08%-74.68%-9,210.61%
FCF Margin -21.59%-255.26%77.21%-5.50%-2,236.93%-114,348.52%-4.18%-18,372.73%-15,736.00%-9,222.02%-5.34%-11,287.16%-8,492.31%-8,674.57%-7,923.08%-76.53%-9,716.67%
Efficiency
Assets Average 53.54M68.48M83.76M156.69M227.73M212.54M200.82M192.82M184.21M171.18M160.15M149.32M139.80M130.63M134.53M137.82M124.85M110.37M97.41M86.91M79.54M70.64M
Equity Average 40.96M47.06M53.64M132.37M213.91M201.87M188.38M172.37M158.57M147.10M137.16M126.61M115.82M106.00M94.54M83.04M83.59M82.60M72.26M63.75M57.53M50.24M
Invested Capital 51.46M30.49M63.87M46.00M221.11M206.71M197.02M179.75M165.00M152.15M142.05M132.27M120.95M110.70M101.29M87.80M78.28M88.90M76.29M68.23M59.28M55.79M44.70M
Asset Utilization Ratio 0.151.410.971.012.141.151.201.301.401.491.591.711.661.621.792.020.010.010.080.09
Leverage & Solvency
Debt to Equity 0.010.010.000.06
Debt Ratio 0.000.010.000.03
Equity Ratio 0.830.670.690.570.930.950.950.920.860.860.860.850.840.810.810.610.590.750.740.740.730.720.70
Valuation
Enterprise Value -58.33M-41.25M-86.87M-72.03M-233.05M-212.20M-201.80M-187.80M-168.60M-152.37M-137.86M-129.00M-117.72M-96.52M-87.07M-105.83M-90.26M-76.97M-62.71M-53.08M-43.00M-38.35M-25.60M
Return Ratios
Return on Sales -2.38%-3.86%0.84%0.55%0.59%-0.12%-17.90%-0.31%-1,077.98%-0.05%-202.36%-165.44%-103.24%-0.07%-79.01%50.42%-80.96%-53.94%-78.73%-0.75%-92.11%
Return on Capital Employed -1.32%0.82%0.57%0.64%0.67%-0.36%-0.38%-0.42%-0.44%-0.48%-0.48%-0.62%-0.70%-0.71%-0.73%-0.59%-0.64%
Return on Invested Capital 0.65%-0.40%-0.43%-0.47%-0.41%
Return on Assets -0.97%0.73%0.53%0.60%0.61%-0.36%-0.37%-0.40%-0.34%-0.34%-0.35%-0.37%-0.39%-0.37%-0.24%-0.29%-0.27%-0.29%-0.48%-0.51%
Return on Equity -1.51%0.87%0.57%0.63%0.65%-0.40%-0.43%-0.47%-0.39%-0.41%-0.43%-0.46%-0.55%-0.61%-0.36%-0.39%-0.37%-0.39%-0.66%-0.72%